Amy Walker

Dr. Walker joined the Company in November 2020 where she now serves as Chief Operating Officer and EVP of Research. Dr. Walker has a background in molecular biology and gene editing technologies, along with associated nucleic acid nanoparticle delivery platforms. She holds a PhD from UCL Institute of Child Health and was awarded the prestigious Bogue Fellowship, conducting part of her doctoral studies at both University of British Colombia and McGill University, Montreal. Dr. Walker has 8+ years scientific and commercial experience in life sciences, has published scientific papers and is named inventor on a multitude of multidisciplinary patents. She currently holds non-executive director Board positions on several high growth healthcare companies.